Home Cart Sign in  
Chemical Structure| 16830-15-2 Chemical Structure| 16830-15-2

Structure of Asiaticoside
CAS No.: 16830-15-2

Chemical Structure| 16830-15-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Asiaticoside, a natural product isolated and purified from the herbs of Centella asiatica (L.) Urban with antioxidant, anti-inflammatory, antipyretic, anxiolytic-like, antidepressant-like, hepatoprotective and significant wound healing activity, suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts, and is a biochemical modulator that induce apoptosis.

Synonyms: Ba 2742; NSC 166062; Emdecassol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Asiaticoside

CAS No. :16830-15-2
Formula : C48H78O19
M.W : 959.12
SMILES Code : C[C@@H]1CC[C@@]2(C(O[C@@H]3O[C@H](CO[C@H]4[C@H](O)[C@@H](O)[C@H](O[C@@]5([H])[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)[C@@H](CO)O4)[C@@H](O)[C@H](O)[C@H]3O)=O)[C@@](C6=CC[C@@]([C@](C[C@@H](O)[C@H](O)[C@]7(CO)C)(C)[C@@]7([H])CC8)([H])[C@]8(C)[C@]6(C)CC2)([H])[C@H]1C
Synonyms :
Ba 2742; NSC 166062; Emdecassol
MDL No. :MFCD31657273

Safety of Asiaticoside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human brain microvascular endothelial cells (hBMECs) 25, 50, 100 μM 12-hour pretreatment followed by 24-hour exposure to Aβ1-42 Asiaticoside significantly attenuated Aβ1-42-induced cell growth inhibition and apoptosis, restored declined mitochondrial membrane potential, downregulated the expressions of TNF-α, IL-6, TLR4, MyD88, TRAF6, and p-NF-κB p65, and inhibited NF-κB p65 translocation from cytoplasm to nucleus. PMC5797575
LoVo 0.1, 0.5, 2 µM 24, 48, 72 hours Inhibited CRC cell proliferation in a time- and dose-dependent manner PMC7447327
SW480 0.1, 0.5, 2 µM 24, 48, 72 hours Inhibited CRC cell proliferation in a time- and dose-dependent manner PMC7447327
HCT116 0.1, 0.5, 2 µM 24, 48, 72 hours Inhibited CRC cell proliferation in a time- and dose-dependent manner PMC7447327
MCF-7 cells 20, 40, 80 μM 48 hours To evaluate the effect of Asiaticoside on MCF-7 cell growth, results showed that Asiaticoside significantly increased caspase-9 activity and inhibited cell growth. PMC10003851
Rat glomerular mesangial cells (HBZY-1) 0, 2, 4, 8 μM 48 hours To evaluate the effect of AC on high glucose-induced proliferation of HBZY-1 cells. Results showed that AC at high doses (4 μM and 8 μM) effectively inhibited HG-induced proliferation of HBZY-1 cells. PMC11525727
Human peritoneal mesothelial cells HMrSV5 50-150 μM 6-24 hours Asiaticoside inhibited TGF-β1-induced MMT and ROS generation via activation of the Nrf2/HO-1 signaling pathway. PMC7257216
FHC 0.1-8 µM 72 hours No significant effects PMC7447327
HaCaT cells 240 μM To investigate the effect of ACNO on the expression of proteins such as SRC, STAT3 in HaCaT cells under hyperglycemic conditions PMC11891651

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Streptozotocin-induced diabetic nephropathy model Gavage 10 mg/kg/day Once daily for 4 weeks To assess the protective effects of AC on a diabetic nephropathy rat model. Results showed that AC significantly reduced body weight, blood glucose, serum creatinine, blood urea nitrogen, and 24-h urinary protein levels, and improved renal pathological changes in DN rats. PMC11525727
Nude mice MCF-7 tumor xenograft model Intraperitoneal injection 150 mg/kg Once per week for 8 weeks To evaluate the effect of Asiaticoside on tumor growth, results showed that Asiaticoside significantly inhibited TNF-α and IL-6 expression and suppressed tumor growth via the NF-κB pathway. PMC10003851
ICR mice Chronic restraint stress (CRS)-induced depression model Oral 20 mg/kg Once daily for 28 days Asiaticoside significantly ameliorated CRS-induced depressive symptoms, as evidenced by increased sucrose preference and reduced immobility time. At the molecular level, asiaticoside enhanced the expression of BDNF, pTrkB, pNrf2, GPX4, and SLC7A11, indicating its neuroprotective and antioxidative effects. In addition, asiaticoside suppressed the expression of ferroptosis markers, including FLC and transferrin receptor only in CA1 region. TEM further confirmed that asiaticoside preserved mitochondrial integrity in CA1 neuronal cells. PMC11808218
C57/BL6 mice Aβ1-42-induced Alzheimer's disease mouse model Intragastric administration 40 mg/kg 2-14 days AS mitigated cognitive dysfunction and neuroinflammation in Aβ1-42-induced mice by inhibiting the p38 MAPK pathway and promoting synaptic repair. PMC10418370
C57BL/6 mice ZEA-induced uterine injury model Oral 40 mg/kg Once daily for 14 days AS ameliorates ZEA-induced uterine injury by activating the Nrf2 signaling pathway, upregulating the expression of tight junction proteins (ZO-1, occludin, and claudin-3), and inhibiting ZEA-induced apoptosis in uterine tissues via the PI3K/Akt signaling pathway. PMC11395188
Mice Schistosoma mansoni infection model Oral 400 mg/kg Single dose Evaluate the in vivo antischistosomal activity of Asiaticoside against Schistosoma mansoni, showing significant reduction in total worm load and egg burden PMC9143675
BALB/c-nude mice Xenograft mouse model Oral gavage 5, 10 mg/kg Every 2 days for 6 weeks Significantly inhibited tumor growth in a dose-dependent manner PMC7447327
C57BL/6 mice MNU-induced retinal degeneration model Oral 50, 100, and 200 mg/kg Once daily for seven days To evaluate the protective effect of CA-HE50 against MNU-induced retinal degeneration, results showed that CA-HE50 significantly increased the thickness of photoreceptors and the outer nuclear layer (ONL) and the number of nuclei in the ONL. PMC8072678
C57BL/6 mice Chronic unpredictable mild stress (CUMS) depression model Oral gavage Low dose (10 mg/kg), medium dose (20 mg/kg), high dose (40 mg/kg) Once daily for 4 weeks Asiaticoside significantly improved depression-like behavior in CUMS mice, partially restored gut microbial community structure, altered SCFA metabolism, regulated HPA axis and inflammatory factor levels, upregulated hippocampal BDNF and 5-HT1A receptor protein expression, and increased serum 5-HT concentration. PMC11527651

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.04mL

0.21mL

0.10mL

5.21mL

1.04mL

0.52mL

10.43mL

2.09mL

1.04mL

References

 

Historical Records

Categories